Stockreport

Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease [Yahoo! Finance]

Supernus Pharmaceuticals, Inc.  (SUPN) 
Last supernus pharmaceuticals, inc. earnings: 2/25 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.supernus.com
PDF under FDA review for the continuous treatment of motor fluctuations (“off” episodes) in Parkinson's disease (PD) The FDA has issued a Complete Response Letter (CRL) in [Read more]